Cargando…
Lenalidomide-Associated Hemophagocytic Lymphohistiocytosis With Plasma Cell Phagocytosis
Hemophagocytic lymphohistiocytosis (HLH) is a severe systemic inflammatory syndrome that is often fatal. In the adult population, it is believed to develop secondary to immune dysregulation due to rheumatologic, infectious, malignant, and recently, immunomodulatory drugs. It’s co-occurrence with pha...
Autores principales: | Runge, Elliot, Kou, Chung-ting J, Rendo, Matthew, Lynch, David, Fenderson, Joshua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110293/ https://www.ncbi.nlm.nih.gov/pubmed/33987058 http://dx.doi.org/10.7759/cureus.14409 |
Ejemplares similares
-
Neutropenic Fever in a Patient With SARS-CoV-2-Induced Hemophagocytic Lymphohistiocytosis (HLH)
por: Runge, Elliot, et al.
Publicado: (2021) -
Hemophagocytic lymphohistiocytosis as an etiology of bone marrow failure
por: Paolino, Jonathan, et al.
Publicado: (2022) -
Successful Modified Therapy in a Patient with Probable Infection-Associated Hemophagocytic Lymphohistiocytosis
por: Kay, Carl L., et al.
Publicado: (2019) -
Pulmonary Lymphomatoid Granulomatosis With Hemophagocytic Lymphohistiocytosis as the Initial Manifestation
por: Xu, Li, et al.
Publicado: (2020) -
Prognostic value of lipid profile in adult hemophagocytic lymphohistiocytosis
por: Cheng, Wanying, et al.
Publicado: (2023)